↓ Skip to main content

C-Reactive Protein, Fatal and Nonfatal Coronary Artery Disease, Stroke, and Peripheral Artery Disease in the Prospective EPIC-Norfolk Cohort Study

Overview of attention for article published in Arteriosclerosis, Thrombosis, and Vascular Biology (Highwire), September 2013
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
2 X users
patent
2 patents

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
C-Reactive Protein, Fatal and Nonfatal Coronary Artery Disease, Stroke, and Peripheral Artery Disease in the Prospective EPIC-Norfolk Cohort Study
Published in
Arteriosclerosis, Thrombosis, and Vascular Biology (Highwire), September 2013
DOI 10.1161/atvbaha.113.301736
Pubmed ID
Authors

Diederik F. van Wijk, S. Matthijs Boekholdt, Nicholas J. Wareham, Sara Ahmadi-Abhari, John J.P. Kastelein, Erik S.G. Stroes, Kay-Tee Khaw

Abstract

Circulating levels of C-reactive protein (CRP) are associated with an increased risk of coronary artery disease (CAD), stroke, and peripheral artery disease (PAD). Observational and experimental evidence suggest that CRP might differentially predict fatal and nonfatal cardiovascular events. Here, we sought to determine the predictive value of CRP for fatal and nonfatal CAD, stroke, or PAD.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
Netherlands 1 3%
Unknown 38 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 18%
Student > Master 5 13%
Student > Bachelor 4 10%
Student > Ph. D. Student 3 8%
Other 3 8%
Other 11 28%
Unknown 7 18%
Readers by discipline Count As %
Medicine and Dentistry 21 53%
Biochemistry, Genetics and Molecular Biology 2 5%
Nursing and Health Professions 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Psychology 1 3%
Other 1 3%
Unknown 12 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2019.
All research outputs
#7,369,852
of 25,411,814 outputs
Outputs from Arteriosclerosis, Thrombosis, and Vascular Biology (Highwire)
#2,158
of 6,066 outputs
Outputs of similar age
#61,314
of 215,443 outputs
Outputs of similar age from Arteriosclerosis, Thrombosis, and Vascular Biology (Highwire)
#10
of 52 outputs
Altmetric has tracked 25,411,814 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 6,066 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,443 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.